X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2201) 2201
Publication (270) 270
Book Review (53) 53
Newsletter (38) 38
Book Chapter (22) 22
Magazine Article (11) 11
Newspaper Article (5) 5
Book / eBook (3) 3
Conference Proceeding (3) 3
Dissertation (2) 2
Data Set (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1496) 1496
index medicus (1194) 1194
animals (982) 982
female (794) 794
immunology (688) 688
male (510) 510
viruses (486) 486
vaccines (442) 442
health aspects (436) 436
mice (434) 434
medicine, research & experimental (419) 419
infections (418) 418
vaccination (390) 390
infection (367) 367
antiviral agents - therapeutic use (334) 334
adult (320) 320
virology (294) 294
infectious diseases (283) 283
virus diseases (281) 281
research (276) 276
middle aged (251) 251
herpesvirus 3, human - immunology (250) 250
immunization (247) 247
antibodies, viral - blood (230) 230
microbiology (218) 218
vaccine (216) 216
child (202) 202
herpes viruses (198) 198
allergy and immunology (197) 197
article (193) 193
analysis (187) 187
proteins (187) 187
aged (186) 186
herpes-simplex-virus (181) 181
cancer (180) 180
herpes simplex (180) 180
veterinary sciences (180) 180
antigens (178) 178
acyclovir - therapeutic use (172) 172
mice, inbred balb c (171) 171
herpes simplex virus (170) 170
immunotherapy (169) 169
lymphocytes (169) 169
research article (167) 167
oncology (166) 166
care and treatment (165) 165
herpesvirus 2, human - immunology (160) 160
herpesvirus 4, human - immunology (160) 160
viral vaccines - therapeutic use (160) 160
t cells (158) 158
adolescent (155) 155
herpes (155) 155
prevention (155) 155
medical research (153) 153
risk factors (149) 149
immune response (147) 147
disease (146) 146
epstein-barr-virus (146) 146
viral vaccines - immunology (145) 145
herpes zoster - prevention & control (144) 144
epstein-barr virus (141) 141
herpesvirus diseases (140) 140
immune system (140) 140
medicine (138) 138
disease models, animal (135) 135
acyclovir (134) 134
herpesvirus 1, human - genetics (133) 133
dna (130) 130
epidemiology (129) 129
antibodies (128) 128
herpesvirus 1, human - immunology (128) 128
chickenpox - prevention & control (127) 127
immunity (127) 127
antiviral agents (126) 126
biotechnology & applied microbiology (126) 126
child, preschool (126) 126
gene expression (126) 126
genital herpes (126) 126
expression (124) 124
studies (122) 122
cattle (120) 120
herpesvirus (120) 120
cell line (119) 119
chickenpox (119) 119
deoxyribonucleic acid--dna (119) 119
varicella (118) 118
virus (117) 117
shingles (116) 116
pharmacology & pharmacy (115) 115
hiv (114) 114
cercopithecus aethiops (113) 113
multidisciplinary sciences (113) 113
treatment outcome (112) 112
dendritic cells (111) 111
viral envelope proteins - immunology (111) 111
genetic aspects (110) 110
enzyme-linked immunosorbent assay (109) 109
herpes genitalis - prevention & control (109) 109
viral infections (109) 109
biology (106) 106
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2195) 2195
Dutch (21) 21
French (17) 17
German (13) 13
Japanese (12) 12
Russian (9) 9
Chinese (2) 2
Czech (2) 2
Spanish (2) 2
Croatian (1) 1
Italian (1) 1
Polish (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 49, pp. 7046 - 7051
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 12/2007, Volume 196, Issue 12, pp. 1749 - 1753
Journal Article
Drugs & Aging, ISSN 1170-229X, 02/2010, Volume 27, Issue 2, pp. 159 - 176
Individuals who have been infected with varicella zoster virus (VZV) are at risk for developing herpes zoster and this risk appears to be related to a decline... 
Herpes-zoster, prevention | Adis-Drug-Evaluations | Varicella-zoster-virus-vaccine-live, pharmacodynam | Varicella-zoster-virus-vaccine-live, pharmacokinet | Postherpetic-neuralgia, prevention | Varicella-zoster-virus-vaccine-live, therapeutic u | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | Varicella-zoster-virus-vaccine-live, pharmacokinetics | Herpes-zoster, Prevention | Varicella-zoster-virus-vaccine-live, pharmacodynamics | Varicella-zoster-virus- vaccine-live, therapeutic use | COST-EFFECTIVENESS | IMMUNOGENICITY | MANAGEMENT | SAFETY | IMMUNE-RESPONSES | PHARMACOLOGY & PHARMACY | GERIATRICS & GERONTOLOGY | Herpes Zoster - prevention & control | Age Factors | Humans | Vaccination | Cost of Illness | Herpesvirus 3, Human - immunology | Vaccines, Attenuated - economics | Incidence | Neuralgia, Postherpetic - prevention & control | Neuralgia, Postherpetic - immunology | Vaccines, Attenuated - administration & dosage | Neuralgia, Postherpetic - epidemiology | Adult | Herpes Zoster - epidemiology | Chickenpox Vaccine - economics | Cost-Benefit Analysis - economics | Herpes Zoster - immunology | Risk Factors | Immunocompetence - immunology | Treatment Outcome | Chickenpox Vaccine - administration & dosage | Health Services for the Aged | Herpes Zoster Vaccine - economics | Herpes Zoster Vaccine - administration & dosage | Randomized Controlled Trials as Topic | Immunity, Cellular - immunology | Antibodies, Viral - immunology | Immunologic Memory | Prevention | Complications and side effects | Shingles (Disease) | Herpesvirus vaccines | Aged | Dosage and administration | Research | Neuralgia | Health aspects | Risk factors
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2013, Volume 8, Issue 8, p. e71322
Millions of people worldwide are currently infected with human papillomavirus (HPV), herpes simplex virus (HSV) or human immunodeficiency virus (HIV). For this... 
HERPESVIRUS ENTRY MEDIATOR | HUMAN-PAPILLOMAVIRUS TYPE-16 | GENE | MULTIDISCIPLINARY SCIENCES | DOUBLE-BLIND | VACCINATION | TNFR FAMILY | NF-KAPPA-B | EXPRESSION | VIRUS TYPE-1 | GLYCOPROTEIN-D | HIV Infections - prevention & control | Vaccines, DNA - genetics | Humans | AIDS Vaccines - immunology | Vaccines, DNA - immunology | Antigens, Viral - genetics | AIDS Vaccines - therapeutic use | HIV - immunology | Alphapapillomavirus - immunology | Herpes Simplex Virus Vaccines - immunology | HIV Infections - immunology | Herpes Simplex Virus Vaccines - therapeutic use | Papillomavirus Infections - immunology | Female | Immunization | Papillomavirus Vaccines - therapeutic use | Mice, Inbred C57BL | Simplexvirus - genetics | Vaccines, DNA - therapeutic use | Herpes Simplex - immunology | Antigens, Viral - immunology | Alphapapillomavirus - genetics | Animals | Papillomavirus Infections - prevention & control | HIV - genetics | Herpes Simplex - prevention & control | Papillomavirus Vaccines - immunology | Mice | Mice, Inbred BALB C | Simplexvirus - immunology | CD8-Positive T-Lymphocytes - immunology | Surgical implants | Laboratories | CD8 antigen | Herpes simplex | Cytotoxicity | Viruses | Lymphocytes T | Infections | DNA vaccines | Vaccines | Immunity | Proteins | Human papillomavirus | Immunology | Gag protein | Lymphocytes | Human immunodeficiency virus--HIV | Deoxyribonucleic acid--DNA | Antigens | Tumor cells | Latent infection | Envelope protein | Implantation | T cell receptors | Gene expression | Virology | Medicine | Herpes viruses | Genetic engineering | Cancer | Tumors | Deoxyribonucleic acid | HIV | DNA | Human immunodeficiency virus
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 10/2017, Volume 69, Issue 10, pp. 1969 - 1977
Objective Patients with rheumatoid arthritis (RA) are at increased risk of herpes zoster, and vaccination is recommended for patients ages 50 years and older,... 
RESPONSES | MODIFYING ANTIRHEUMATIC DRUGS | EFFICACY | HERPES-ZOSTER | AMERICAN-COLLEGE | METHOTREXATE | RHEUMATOLOGY | COMBINATION | RECIPIENTS | CP-690,550 | Herpes Zoster - prevention & control | Double-Blind Method | Enzyme-Linked Immunosorbent Assay | Humans | Middle Aged | Herpesvirus 3, Human - immunology | Male | Enzyme-Linked Immunospot Assay | Herpes Zoster Vaccine - therapeutic use | Methotrexate - therapeutic use | Arthritis, Rheumatoid - drug therapy | Immunoglobulin G - immunology | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Antibodies, Viral - immunology | Female | T-Lymphocytes - immunology | Aged | Drug Therapy, Combination | Pyrroles - therapeutic use | Immunogenicity, Vaccine - immunology | Antirheumatic Agents - therapeutic use | Herpes Zoster Vaccine - immunology | Immunoglobulin G | Vaccination | Viruses | Leukocytes (mononuclear) | Lymphocytes T | Arthritis | Vaccines | Immunity | Randomization | Lymphocytes | Varicella | Peripheral blood mononuclear cells | Safety | Methotrexate | Active control | Age | Enzyme-linked immunosorbent assay | Immune system | Enzymes | Herpes zoster | Immune response | Enumeration | Immune response (cell-mediated) | Glycoprotein | Patients | Immune response (humoral) | Immunogenicity | Rheumatoid arthritis | Rheumatoid Arthritis
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 3/2008, Volume 197, Issue 6, pp. 825 - 835
Journal Article
Journal of Virology, ISSN 0022-538X, 2015, Volume 89, Issue 13, pp. 6619 - 6632
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 44, pp. 5314 - 5320
Journal Article
Science Translational Medicine, ISSN 1946-6234, 11/2011, Volume 3, Issue 107, pp. 107fs7 - 107fs7
Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical... 
MEDICINE, RESEARCH & EXPERIMENTAL | INFECTIOUS-MONONUCLEOSIS | GP350 VACCINE | LYMPHOMA | PHASE-I TRIAL | CELL BIOLOGY | Infectious Mononucleosis - prevention & control | Neoplasms - virology